BE1001932A4 - Compositions pharmaceutique facilitant la cicatrisation des blessures et procedes pour sa preparation. - Google Patents

Compositions pharmaceutique facilitant la cicatrisation des blessures et procedes pour sa preparation. Download PDF

Info

Publication number
BE1001932A4
BE1001932A4 BE8800899A BE8800899A BE1001932A4 BE 1001932 A4 BE1001932 A4 BE 1001932A4 BE 8800899 A BE8800899 A BE 8800899A BE 8800899 A BE8800899 A BE 8800899A BE 1001932 A4 BE1001932 A4 BE 1001932A4
Authority
BE
Belgium
Prior art keywords
weight
support
solution containing
wound
wounds
Prior art date
Application number
BE8800899A
Other languages
English (en)
French (fr)
Inventor
Janos Balini
Sandor Jancso
Tamas Farago
Janos Erdei
Istvan Kovacs
Zsuzsanna Emri
Katalin Horvath
Original Assignee
Biogal Gyogyszergyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogal Gyogyszergyar filed Critical Biogal Gyogyszergyar
Application granted granted Critical
Publication of BE1001932A4 publication Critical patent/BE1001932A4/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/425—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/432—Inhibitors, antagonists
    • A61L2300/436—Inhibitors, antagonists of receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/80—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special chemical form
    • A61L2300/802—Additives, excipients, e.g. cyclodextrins, fatty acids, surfactants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Materials Engineering (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
BE8800899A 1987-08-04 1988-08-03 Compositions pharmaceutique facilitant la cicatrisation des blessures et procedes pour sa preparation. BE1001932A4 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU873554A HU201683B (en) 1987-08-04 1987-08-04 Process for producing pharmaceutical compositions for promoting healing of wounds

Publications (1)

Publication Number Publication Date
BE1001932A4 true BE1001932A4 (fr) 1990-04-17

Family

ID=10964527

Family Applications (1)

Application Number Title Priority Date Filing Date
BE8800899A BE1001932A4 (fr) 1987-08-04 1988-08-03 Compositions pharmaceutique facilitant la cicatrisation des blessures et procedes pour sa preparation.

Country Status (16)

Country Link
JP (1) JPH01117828A (de)
AU (1) AU612387B2 (de)
BE (1) BE1001932A4 (de)
BG (1) BG49522A1 (de)
CH (1) CH675833A5 (de)
CS (1) CS274600B2 (de)
DD (1) DD272414A5 (de)
DE (1) DE3826419A1 (de)
ES (1) ES2007544A6 (de)
FI (1) FI883638A (de)
FR (1) FR2619011A1 (de)
GB (1) GB2207865B (de)
HU (1) HU201683B (de)
IT (1) IT1226586B (de)
NL (1) NL8801930A (de)
SE (1) SE8802805L (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU627775B2 (en) * 1988-09-20 1992-09-03 Glaxo Group Limited Pharmaceutical compositions
IT1241521B (it) * 1990-07-31 1994-01-17 Polifarma Spa Impiego teperautico della ranitidina nella cura di ferite interessantila cute e i tessuti sottostanti
GB9102660D0 (en) * 1991-02-07 1991-03-27 Ultra Lab Ltd Wound dressing materials
DE4220736A1 (de) * 1992-06-25 1994-01-05 Puetter Medice Chem Pharm Einschlußkomplexe aus polymerisierten Cyclodextrinen mit pharmazeutisch aktiven Wirkstoffen
GB9424562D0 (en) 1994-12-06 1995-01-25 Giltech Ltd Product
DE9420259U1 (de) * 1994-12-17 1995-02-09 Röhm GmbH, 64293 Darmstadt Entbittertes Ranitidin-Präparat
TWI221768B (en) * 1996-08-16 2004-10-11 Schering Corp Pharmaceutical composition comprising histamine H1 receptor antagonist and histamine H3 receptor antagonist providing nasal decongestant effect
US5869479A (en) * 1997-08-14 1999-02-09 Schering Corporation Treatment of upper airway allergic responses
JP2001139477A (ja) * 1999-11-17 2001-05-22 Coherent Technology:Kk 創傷部位の組織細胞増殖促進液
DE10355085A1 (de) * 2003-11-24 2005-06-23 Schure, Frank, Dr. Wundverband
CN103816560B (zh) * 2014-03-03 2015-06-24 广西南宁博恩康生物科技有限公司 一种用于创口修复的胶体液及其制备方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2215230A1 (de) * 1973-01-29 1974-08-23 Pharmacia Ab
EP0194647A2 (de) * 1985-03-12 1986-09-17 Johnson & Johnson Products Inc. Debridementband
GB2191693A (en) * 1986-06-18 1987-12-23 Frederick Jacob Bloomfield Anti-inflammatory agents
US4747845A (en) * 1983-10-17 1988-05-31 Enquay Pharmaceutical Associates Synthetic resin matrix system for the extended delivery of drugs

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2215230A1 (de) * 1973-01-29 1974-08-23 Pharmacia Ab
US4747845A (en) * 1983-10-17 1988-05-31 Enquay Pharmaceutical Associates Synthetic resin matrix system for the extended delivery of drugs
EP0194647A2 (de) * 1985-03-12 1986-09-17 Johnson & Johnson Products Inc. Debridementband
GB2191693A (en) * 1986-06-18 1987-12-23 Frederick Jacob Bloomfield Anti-inflammatory agents

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACTS, vol. 106, no. 17, 27 avril 1987, page 62, résumé no. 131677f, Columbus, Ohio, US; S. MOHAMED et al.: "Wound healing properties of cimetidine in vitro", & DRUG INTELL. CLIN. PHARM. 1986, 20(12),973-5 *

Also Published As

Publication number Publication date
CS274600B2 (en) 1991-08-13
HUT47848A (en) 1989-04-28
IT8821634A0 (it) 1988-08-03
SE8802805L (sv) 1989-02-05
SE8802805D0 (sv) 1988-08-03
DD272414A5 (de) 1989-10-11
AU2038788A (en) 1989-02-09
HU201683B (en) 1990-12-28
FI883638A (fi) 1989-02-05
AU612387B2 (en) 1991-07-11
NL8801930A (nl) 1989-03-01
GB2207865B (en) 1991-10-09
BG49522A1 (en) 1991-12-16
GB2207865A (en) 1989-02-15
CH675833A5 (de) 1990-11-15
ES2007544A6 (es) 1989-06-16
JPH01117828A (ja) 1989-05-10
GB8818575D0 (en) 1988-09-07
FR2619011A1 (fr) 1989-02-10
DE3826419A1 (de) 1989-02-16
FI883638A0 (fi) 1988-08-03
CS543688A2 (en) 1990-10-12
IT1226586B (it) 1991-01-24

Similar Documents

Publication Publication Date Title
DE69032125T2 (de) Gelwundverbandszusammensetzungen und verfahren zu deren gebrauch
DE60116052T2 (de) Polymermischungen als bioabbaubare matrizen zur herstellung von biokompositen
DE602004002717T2 (de) Blattförmige Wundauflage aus mikrobieller Zellulose, enthaltend PHMB, für chronische Wunden
BR112020007534A2 (pt) composições superabsorventes antimicrobianas
FR2596991A1 (fr) Medicament sous forme liquide pour le traitement du psoriasis, a base de polymeres filmogenes
BE1001932A4 (fr) Compositions pharmaceutique facilitant la cicatrisation des blessures et procedes pour sa preparation.
FR2464068A1 (fr) Compositions a base de dimethylsulfoxyde et leurs applications, notamment en therapeutique
BRPI0717734B1 (pt) Método para preparar um pó seco de nanopartículas poliméricas, pó seco e uso do mesmo
WO2011157880A1 (es) Composición antioxidante
RU2389483C2 (ru) Химически устойчивые композиции 4-гидрокси-тамоксифена
EP2030612B1 (de) Pharmazeutische zusammensetzung zur behandlung von verbrennungen und verfahren zu ihrer herstellung
CA2883455C (en) Improved wound healing compositions comprising microspheres
KR101367340B1 (ko) 아미노산 및 히알루론산 나트륨에 기반한 멸균 분말 제형의상처-치료용 약학적 조성물
EP0285856B1 (de) Verwendung von Dihydroergotamin und seinen Salzen zur lokalen Behandlung trophischer Störungen
US11058712B2 (en) Film for topical application in the treatment of skin lesions and method of obtaining and applying same
EP3010516B1 (de) Heilungszusammensetzung und verwendung davon
RU2603490C1 (ru) Средство для лечения гнойно-воспалительных процессов мягких тканей и слизистых оболочек
RU2601897C1 (ru) Средство для лечения гнойно-воспалительных процессов мягких тканей и слизистых оболочек
RU2605343C1 (ru) Средство для лечения гнойно-воспалительных процессов мягких тканей и слизистых оболочек
FR2565103A1 (fr) Composition pharmaceutique liberant graduellement de l'iode
RU2536266C2 (ru) Крем медицинского назначения, изготовленный с использованием фрамицетина сульфата и хитозана, и способ его изготовления
CA2434608C (fr) Favorisation de la reconstruction cellulaire et/ou de la differenciation cellulaire avec sucre non metabolisable et un absorbant polymerique
LU84509A1 (fr) Composition de cromoglycate de sodium,emballage et procede pour preparer la composition
JPH03167123A (ja) 褥瘡用医薬品
RU2124355C1 (ru) Способ создания средства для лечения ран

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: BIOGAL GYOGYSZERGYAR

Effective date: 19920831